Immunogen reported $296.8M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Agios Pharmaceuticals AGIO:US $ 1541.5M 333.1M
Amgen AMGN:US $ 64993M 5220M
Arena Pharmaceuticals ARNA:US $ 901.03M 183.63M
Astellas Pharma 4503:JP Y 2261508M 12052M
AstraZeneca AZN:LN 107221M 33580M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Bristol Myers Squibb BMY:US $ 110893M 96M
Cerulean Pharma CERU:US $ 48.81M 33.99M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Eli Lilly And LLY:US $ 48187M 378M
Emergent Biosolutions EBS:US $ 2867.5M 47.7M
Exelixis EXEL:US $ 2447.74M 80.47M
Halozyme Therapeutics HALO:US $ 1185.42M 159.56M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Immunogen IMGN:US $ 296.8M 4.64M
Intrexon XON:US $ 376.9M 25.67M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Macrogenics MGNX:US $ 392.16M 33.75M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Novartis NVS:US $ 121209M 2806M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Seattle Genetics SGEN:US $ 3977.88M 25.72M